Test Price
1,200 AED✅ Home Collection Available
MYD88 Gene Mutation Analysis in UAE | 1,200 AED | DHA Licensed Molecular Diagnostics
Executive Summary & Core Metrics
Executive Summary: High-precision MYD88 L265P mutation analysis using Sanger sequencing gold-standard methodology, with ISO 9001:2015 accredited processing and DHA-licensed clinical oversight by a Consultant Medical Genetics specialist.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed Consultant Medical Genetics.
- Insurance: Direct Billing Verification via WhatsApp: +971 54 548 8731.
Test Overview & Methodology
The MYD88 Gene Mutation Analysis detects somatic mutations in the MYD88 gene, most notably the L265P variant, a hallmark of Waldenström macroglobulinemia and activated B‑cell lymphomas. This Sanger sequencing‑based assay delivers definitive genotyping to guide targeted therapy decisions, with results within 5–7 days.
| Parameter | Our Test | Closest Alternative |
|---|---|---|
| Method | Sanger Sequencing – Gold Standard | NGS Panel (may need Sanger confirmation) |
| Precision | Single‑nucleotide resolution, targeted L265P hotspot | Varies; often requires orthogonal validation |
| Turnaround Time | 5–7 days | 10–14 days typical |
| Accreditation | ISO 9001:2015 + DHA Licensed | May vary by provider |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics specialist, I recognize the profound impact a precise MYD88 mutation result can have on your treatment journey. It is critical to interpret this result alongside your full clinical picture—never in isolation. Please continue all prescribed medications and consult your managing physician before making any changes.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Clinical Advisory – Medication Safety
⚠️ Do not discontinue prescribed medication without consulting your doctor.
Always consult your managing physician before stopping, starting, or altering any prescribed therapies based on test results. The MYD88 mutation result is one component of a comprehensive diagnostic workup and must never be used in isolation for treatment decisions.
Exclusion Criteria & Emergency Red Flags
- Recent blood transfusion or allogeneic stem cell transplant may cause donor DNA chimerism, leading to false‑negative results.
- Test not indicated for asymptomatic individuals outside high‑risk familial syndromes or confirmed B‑cell neoplasm workup.
- Pregnancy and planned surgeries: No contraindication to phlebotomy; inform your physician.
- Seek emergency care if you develop sudden severe bleeding, fever >38.5°C, or signs of hyperviscosity (blurred vision, headache, confusion) before or after testing.
Patient FAQ & Clinical Guidance
1. What is the MYD88 L265P mutation and why is it tested?
The MYD88 L265P mutation is a key diagnostic marker for Waldenström macroglobulinemia and ABC‑type diffuse large B‑cell lymphoma. Detecting this somatic variant helps confirm the diagnosis, stratify prognosis, and guide the use of BTK inhibitors. Testing is performed on peripheral blood using Sanger sequencing, which offers definitive single‑nucleotide identification with 99.9% sensitivity.
2. How should I prepare for the MYD88 gene mutation blood test?
No fasting or medication adjustments are required unless specifically directed by your doctor. A prescription from a DHA‑licensed physician is mandatory for testing. Our VIP Mobile Phlebotomy team collects the sample at your home using a temperature‑controlled cold‑chain kit between 8 AM and 11 PM, and you will receive the result within 5–7 days.
3. Is the MYD88 test covered by UAE insurance, and how do I verify?
Many UAE insurers cover genetic mutation analysis for diagnosed or suspected B‑cell neoplasms. Our team will verify your coverage directly via WhatsApp at +971 54 548 8731 before the blood draw, ensuring no surprise bills and transparent direct billing where applicable.
UAE Regulatory & Data Privacy Adherence
UAE Regulatory Compliance: This test is performed in strict adherence to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139). DHA Facility License: 1143.
Clinical & Logistical Metadata
| Test Name | MYD88 Gene Mutation Analysis (L265P Hotspot) |
| Price (AED) | 1,200 AED |
| Turnaround Time | 5–7 working days |
| Sample Type / Matrix | Peripheral whole blood (EDTA tube) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM |
| Methodology Used | Sanger Sequencing – Gold Standard Single-Nucleotide Resolution |
| ICD-10-CM Code | C88.0, C83.30, D84.8 |
| LOINC Code | 83011-4 |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians